Combination of clozapine and escitalopram in treatment of negative symptoms in residual schizophrenia

Trial Profile

Combination of clozapine and escitalopram in treatment of negative symptoms in residual schizophrenia

Completed
Phase of Trial: Phase III

Latest Information Update: 13 Sep 2011

At a glance

  • Drugs Clozapine (Primary) ; Escitalopram (Primary) ; Haloperidol
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Sep 2011 New trial record
    • 07 Sep 2011 Results presented at the 24th Annual Congress of the European College of Neuropsychopharmacology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top